VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,000 | -18.8% | 1,484 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | -20.0% | 1,484 | +20.1% | 0.00% | – |
| Q1 2020 | $20,000 | 0.0% | 1,236 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | +53.8% | 1,236 | +15.8% | 0.00% | – |
| Q3 2019 | $13,000 | -99.8% | 1,067 | -99.7% | 0.00% | -100.0% |
| Q2 2019 | $6,011,000 | -81.9% | 426,726 | -76.4% | 0.03% | -82.7% |
| Q1 2019 | $33,270,000 | +0.0% | 1,808,201 | +42.0% | 0.15% | -7.4% |
| Q4 2018 | $33,268,000 | -17.9% | 1,273,211 | -27.9% | 0.16% | 0.0% |
| Q3 2018 | $40,545,000 | +405350.0% | 1,766,746 | +328291.4% | 0.16% | – |
| Q2 2018 | $10,000 | +25.0% | 538 | -6.3% | 0.00% | – |
| Q1 2018 | $8,000 | 0.0% | 574 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | – | 574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |